Search Results

Filter
  • 1-10 of  1,420,566 results for ""Drug Development""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Challenges and opportunities in oncology drug development and clinical research in China.

  • Authors : Wang F; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou 510060, P.R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou 510060, P.R. China.

Subjects: Drug Development* ; Medical Oncology* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: Cell [Cell] 2024 Mar 28; Vol. 187 (7), pp. 1578-1583.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172

Record details

×
Academic Journal

Moving Beyond Boundaries: Utilization of Longitudinal Exposure-Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm.

  • Authors : Huh Y; Worldwide Development, Research and Medical, Pfizer Inc, 280 Shennecossett Rd, Groton, CT, 06340, USA. .; Wojciechowski J

Subjects: Drug Development* ; Protein Kinase Inhibitors*; Humans

  • Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Mar; Vol. 63 (3), pp. 381-394. Date of Electronic Publication: 2024 Feb 15.Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926

Record details

×
Periodical

Trends in rare disease drug development.

Subjects: Rare Diseases*/Rare Diseases*/Rare Diseases*/drug therapy ; Drug Development*; Humans

  • Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Mar; Vol. 23 (3), pp. 168-169.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Record details

×
Academic Journal

The new direction of drug development: Degradation of undruggable targets through targeting chimera technology.

  • Authors : Liang X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.; Ren H

Subjects: Drug Delivery Systems* ; Drug Development*; Humans

  • Source: Medicinal research reviews [Med Res Rev] 2024 Mar; Vol. 44 (2), pp. 632-685. Date of Electronic Publication: 2023 Nov 20.Publisher: Wiley Country of Publication: United States NLM ID: 8103150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1128

Record details

×
Academic Journal

Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.

Subjects: Drug Development* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Adolescent

  • Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Feb 08; Vol. 116 (2), pp. 200-207.Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development.

  • Authors : Hays A; BioAgilytix Laboratories, Durham, North Carolina, USA. .; Wissel M

Subjects: Drug Development* ; Genetic Therapy*; Tissue Distribution

  • Source: The AAPS journal [AAPS J] 2024 Feb 05; Vol. 26 (1), pp. 24. Date of Electronic Publication: 2024 Feb 05.Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited

Record details

×
Academic Journal

Real-World Evidence for Neonatal Drug Development: Challenges and Opportunities.

  • Authors : Singh K; Pediatric Programs, Critical Path Institute, Tucson, AZ.; Concato J

Subjects: Drug Development*; Humans ; Infant, Newborn

  • Source: The Journal of pediatrics [J Pediatr] 2024 Feb; Vol. 265, pp. 113806. Date of Electronic Publication: 2023 Oct 31.Publisher: Mosby Country of Publication: United States NLM ID: 0375410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6833

Record details

×
Academic Journal

Non-mutagenic impurities - Recent industry experience of using dose durational limits in drug development.

  • Authors : Lortie A; Non-Clinical Drug Safety, Ipsen, Les Ulis, France. Electronic address: .; Martin EA

Subjects: Drug Development* ; Neoplasms*; Animals

  • Source: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2024 Feb; Vol. 147, pp. 105559. Date of Electronic Publication: 2023 Dec 23.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214983 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Learning image representations for anomaly detection: Application to discovery of histological alterations in drug development.

  • Authors : Zingman I; Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH and Co., Biberach an der Riß, Germany. Electronic address: .; Stierstorfer B

Subjects: Neural Networks, Computer* ; Drug Development*; Humans

  • Source: Medical image analysis [Med Image Anal] 2024 Feb; Vol. 92, pp. 103067. Date of Electronic Publication: 2023 Dec 21.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9713490 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group.

  • Authors : Li W; Pharmacokinetic Sciences, Novartis Biomedical Research, East Hanover, New Jersey, USA.; Vazvaei-Smith F

Subjects: Drug Development* ; Research Report*; Humans

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 May; Vol. 115 (5), pp. 939-953. Date of Electronic Publication: 2024 Mar 12.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

×
  • 1-10 of  1,420,566 results for ""Drug Development""